Blood Testing
September 19, 2024
Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.
Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.
Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.
Patients with CLL who had genetic testing before starting treatment were more likely to have better clinical outcomes than patients who were not tested.”
Real-world data shows that covalent BTK inhibitors were the most commonly prescribed first-line therapy in older adults with CLL.
March 2026 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
February 2026 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
MRD-guided ibrutinib-venetoclax significantly improved outcomes for previously untreated patients with CLL compared with ibrutinib or chemoimmunotherapy.
BeiGene and CLL Society partnered on Test Before Treat, educating healthcare providers and CLL / SLL patients about the importance of biomarker testing.
It’s been a month since my last post on progress in my trial of epcoritamab, a bispecific T cell engager (BiTE) for my chronic lymphocytic leukemia.